Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Survey on the Epidermal Growth Factor Receptor (EGFR) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

NCT01106781 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01106781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Survey on the Epidermal Growth Factor Receptor (EGFR) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
January 31, 2014
Enrollment
591 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer